Thames Ventures VCT 2 plc Issue Of Equity

 
TIDMD467 
 

Thames Ventures VCT 2 plc

LEI: 21380035MV1VRYEXPR95

5 April 2023

Issue of Equity

The Directors of Thames Ventures VCT 2 plc announce allotments on 5 April 2023 of Ventures Shares of 0.1p each ("Ventures Shares") pursuant to the Ventures Offer for Subscription which opened on 2 November 2022 and Healthcare Shares of 0.1p each ("Healthcare Shares") pursuant to the Healthcare Offer for Subscription which opened on 26 October 2022 as follows:

 
                   Shares     Average 
                               issue price 
                               per share 
Ventures Shares    333,929    66.00p 
Healthcare Shares  1,533,714  68.34p 
 

Application for these shares to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities will be made shortly. Dealings are expected to commence on or around 14 April 2023.

Following these allotments, the issued share capital and total voting rights (excluding management shares) of the Company are summarised follows:

 
                                                      Voting 
                                           Shares     rights        Voting 
                                          in issue   per share      rights 
DSO D Shares                              7,867,247        232   1,825,201,304 
DP67 Ordinary Shares                     11,192,136        375   4,197,051,000 
Ventures Shares (excluding Mgt Shares)   53,210,344        860  45,760,895,840 
Healthcare Shares (excluding Mgt 
 Shares)                                 23,366,627        860  20,095,299,220 
AIM Shares                                2,695,803      1,146   3,089,390,238 
Total Voting Rights                                             74,967,837,602 
 

The Total Voting Rights of the Company shown above may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

(END) Dow Jones Newswires

April 05, 2023 13:24 ET (17:24 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.